FC
ACAD icon

FORA Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

FORA Capital’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,746
Closed -$297K – 459
2025
Q2 		$297K Buy
+13,746
New +$256K 0.03% 404
2021
Q1 		– Sell
-8,352
Closed -$446K – 735
2020
Q4 		$446K Buy
+8,352
New +$415K 0.07% 309
2020
Q3 		– Sell
-10,893
Closed -$528K – 622
2020
Q2 		$528K Buy
10,893
+4,168
+62% +$200K 0.18% 148
2020
Q1 		$284K Buy
6,725
+4,583
+214% +$189K 0.06% 363
2019
Q4 		$92K Buy
+2,142
New +$93.2K 0.01% 764

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return